Azoy Alexander sold RCUS

June 1, 2026 · Form 4 insider transaction

Azoy Alexander sold 2,562 shares of Arcus Biosciences, Inc. at $25.77 per share, a transaction worth $66.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Disposed (sell-side)
Shares
2,562
Price
$25.77
Total value
$66.0K
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 1, 2026
Filing dateJune 1, 2026
Shares owned after39,581
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.; Consists of 2,562 shares purchased on 5/29/2026 through the Company's Employee Stock Purchase Plan.; The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.67 to $25.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.; Includes the unvested portion of the Reporting Person's RSU grants.

View the original Form 4 on SEC EDGAR